
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Accelerated Enrollment Solutions (AES) has launched a program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemicby transferring clinical trial patients to AES’ dedicated research sites from other research facilities.
To find out more, click






